Literature DB >> 3878297

Distribution of trimethoprim and sulphamethoxazole in blood during treatment with co-trimoxazole.

A Nowak, A Klimowicz, M Kadyków.   

Abstract

Changes in the distribution of sulphamethoxazole and trimethoprim in whole blood, plasma and erythrocytes at steady-state in patients treated with cotrimoxazole have been studied. Unlike sulphamethoxazole, trimethoprim was weakly bound to erythrocytes and was partially liberated when the erythrocytes were rinsed with isotonic saline. The maximal steady-state concentration of trimethoprim in whole blood was 3 mg/l, but calculated on the basis of the concentration determined in erythrocytes it was 1.8 mg/l. Erythrocytes may be of great significance in trimethoprim distribution as carriers of a readily liberated reservoir of the drug. Acetylated sulphamethoxazole derivatives occurred in a higher percentage in erythrocytes at the maximal steady-state concentration (9.9%) than at the level (7.3%), which may help in interpreting the behaviour of this metabolite in other cells in the organism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878297     DOI: 10.1007/bf00547428

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Trimethoprim-sulfamethoxazole: pharmacodynamic effects of urinary pH and impaired renal function. Studies in humans.

Authors:  W A Craig; C M Kunin
Journal:  Ann Intern Med       Date:  1973-04       Impact factor: 25.391

2.  Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses.

Authors:  P Kremers; J Duvivier; C Heusghem
Journal:  J Clin Pharmacol       Date:  1974 Feb-Mar       Impact factor: 3.126

3.  [Comparative bacteriological investigations with the combination trimethoprim/sulfamethoxazole in vitro and in vivo].

Authors:  E Böhni
Journal:  Chemotherapy       Date:  1969       Impact factor: 2.544

4.  Rapid assay for determination of trimethoprim and sulfamethoxazole levels in serum by spectrofluorometry.

Authors:  D M Lichtenwalner; B Suh; B Lorber; A M Sugar
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

5.  Tissue penetration of trimethoprim and sulphonamides.

Authors:  P J Wilkinson; D S Reeves
Journal:  J Antimicrob Chemother       Date:  1979-11       Impact factor: 5.790

6.  [Role of the skin in sulfamethoxazole distribution].

Authors:  A Nowak; M Kadyków; A Klimowicz
Journal:  Pol Tyg Lek       Date:  1983-04-25

7.  [Role of the skin in the distribution of trimethoprim].

Authors:  A Nowak; M Kadyków; A Klimowicz
Journal:  Pol Tyg Lek       Date:  1983-08-29

8.  Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids.

Authors:  J Rieder
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

9.  Distribution of sulfonamides and sulfonamide potentiators between red blood cells, proteins and aqueous phases of the blood of different species.

Authors:  K Berneis; W Boguth
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

10.  Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.

Authors:  T B Vree; Y A Hekster; J E Damsma; E van der Kleijn; W J O'Reilly
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

View more
  3 in total

1.  Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure.

Authors:  Karen Rowland Yeo; Jane R Kenny; Amin Rostami-Hodjegan
Journal:  Eur J Clin Pharmacol       Date:  2013-01-11       Impact factor: 2.953

2.  Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of Tuberculosis.

Authors:  N Alsaad; J A Dijkstra; O W Akkerman; W C M de Lange; D van Soolingen; J G W Kosterink; T S van der Werf; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

3.  Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya.

Authors:  Michael Green; Kephas Otieno; Abraham Katana; Laurence Slutsker; Simon Kariuki; Peter Ouma; Raquel González; Clara Menendez; Feiko ter Kuile; Meghna Desai
Journal:  Malar J       Date:  2016-01-05       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.